4,035 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Gilliland Jeter Wealth Management LLC

Gilliland Jeter Wealth Management LLC acquired a new position in shares of Encompass Health Co. (NYSE:EHC) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 4,035 shares of the company’s stock, valued at approximately $269,000.

Several other large investors have also recently modified their holdings of EHC. Invesco Ltd. raised its stake in shares of Encompass Health by 22.3% during the 3rd quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock worth $266,914,000 after acquiring an additional 724,544 shares in the last quarter. William Blair Investment Management LLC grew its position in Encompass Health by 6.4% during the 3rd quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock worth $381,226,000 after purchasing an additional 342,512 shares during the last quarter. California Public Employees Retirement System grew its position in Encompass Health by 160.5% during the 4th quarter. California Public Employees Retirement System now owns 515,717 shares of the company’s stock worth $34,409,000 after purchasing an additional 317,730 shares during the last quarter. Lisanti Capital Growth LLC purchased a new stake in Encompass Health during the 3rd quarter worth approximately $10,410,000. Finally, FMR LLC grew its position in Encompass Health by 11.6% during the 3rd quarter. FMR LLC now owns 1,374,755 shares of the company’s stock worth $92,329,000 after purchasing an additional 142,633 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC traded down $0.26 during trading hours on Friday, hitting $82.47. The stock had a trading volume of 706,619 shares, compared to its average volume of 756,857. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. The firm has a 50-day moving average price of $78.25 and a 200 day moving average price of $70.87. Encompass Health Co. has a fifty-two week low of $57.55 and a fifty-two week high of $85.84. The firm has a market capitalization of $8.26 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.50 and a beta of 0.94.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. The company had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.88 earnings per share. As a group, research analysts anticipate that Encompass Health Co. will post 4.04 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio is presently 16.22%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Mizuho boosted their target price on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday. Truist Financial boosted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Stephens reaffirmed an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. Barclays upped their price objective on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $86.56.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.